Endometrial Cancer
An Open-label, Multi-Center, Phase 2 Clinical Trial Evaluating Sapanisertib and Serabelisib (PIKTOR) with Paclitaxel, and a Substudy Evaluating PIKTOR with Paclitaxel plus an Insulin-Suppressing Diet, in Patients with Advanced or Recurrent Endometrial Cancer
- Details
ClinicalTrials.gov ID:
NCT06463028
Diagnosis Type:
NA
USOR Number:
- Address
,
P: